Latest news
Loading news…
Coapt
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Chicago, Illinois, United States Founded 2012 11-50 employees For Profit
Coapt is a human-machine interface technology and medical device innovation.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
41
Patents
10
5 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 6
- Mobile apps
- 2
- Downloads (30d)
- 0
- Patents granted
- 10
- Trademarks
- 5
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $128.68K
Company Info
- Founded
- 2012
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Sub-organizations
- 1
- News articles
- 3
- HQ
- Chicago, Illinois, United States
- Region
- Greater Chicago Area, Great Lakes, Midwestern US
Signals & Scores
- Heat score
- Medium
- Growth score
- High
- Trend (7d)
- 0.8
- Trend (30d)
- 3.3
- Trend (90d)
- 3.5
Acquisitions by Coapt
Loading columns…
0 of 0Show
Page 1 / 1
41
professional contacts at Coapt
Contact execs at Coapt →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Coapt
Loading news…
FAQs about Coapt
People who checked this page also checked these
Sectors Coapt invests & acquires in
Browse the full Acquirezy directory.